NASDAQ:SRTS Sensus Healthcare Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $7.68 -0.20 (-2.54%) (As of 06/30/2022 12:00 AM ET) Add Compare Share Today's Range$7.56▼$7.9650-Day Range$7.06▼$9.2252-Week Range$3.21▼$11.96Volume87,300 shsAverage Volume289,548 shsMarket Capitalization$128.09 millionP/E Ratio6.00Dividend YieldN/APrice Target$13.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address SRTS Stock Forecast (MarketRank)Overall MarketRank™2.73 out of 5 starsMedical Sector60th out of 1,433 stocksSurgical & Medical Instruments Industry7th out of 139 stocksAnalyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 3.1 5 -4 -3 -2 -1 - 3.5 Analyst's Opinion Consensus RatingSensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.50, Sensus Healthcare has a forecasted upside of 75.8% from its current price of $7.68.Amount of Analyst CoverageSensus Healthcare has only been the subject of 1 research reports in the past 90 days. Previous Next 4.5 Community Rank Outperform VotesSensus Healthcare has received 172 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSensus Healthcare has received 78 “underperform” votes. (Add your “underperform” vote.)Community SentimentSensus Healthcare has received 68.80% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sensus Healthcare and other stocks. Vote “Outperform” if you believe SRTS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SRTS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSensus Healthcare does not currently pay a dividend.Dividend GrowthSensus Healthcare does not have a long track record of dividend growth. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sensus Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $75,400.00 in company stock.Percentage Held by Insiders24.30% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 20.49% of the stock of Sensus Healthcare is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Sensus Healthcare are expected to grow by 22.37% in the coming year, from $0.76 to $0.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensus Healthcare is 6.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 34.52.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensus Healthcare is 6.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 34.86.Price to Book Value per Share RatioSensus Healthcare has a P/B Ratio of 4.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Sensus Healthcare (NASDAQ:SRTS)Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.Read More SRTS Stock News HeadlinesJune 28, 2022 | finance.yahoo.comHCA Healthcare (HCA) Boosts Cancer Portfolio With McKesson JVJune 16, 2022 | americanbankingnews.comCritical Comparison: Paradigm Medical Industries (OTCMKTS:PDMI) vs. Sensus Healthcare (NASDAQ:SRTS)June 4, 2022 | finance.yahoo.comThose who invested in Sensus Healthcare (NASDAQ:SRTS) a year ago are up 152%May 23, 2022 | finance.yahoo.comWhy Sensus Healthcare, Inc. (SRTS) Might be Well Poised for a SurgeMay 23, 2022 | finance.yahoo.comCorrection: Sensus Healthcare to Participate in the H.C. Wainwright Global Investment ConferenceMay 20, 2022 | finance.yahoo.comWall Street Analysts Think Sensus Healthcare, Inc. (SRTS) Could Surge 53%: Read This Before Placing a BetMay 18, 2022 | finance.yahoo.comSensus Healthcare to Participate in the H.C. Wainwright Global Investment ConferenceMay 12, 2022 | finance.yahoo.comShareholders Would Enjoy A Repeat Of Sensus Healthcare's (NASDAQ:SRTS) Recent Growth In ReturnsMay 5, 2022 | finance.yahoo.comSensus Healthcare First Quarter 2022 Financial Results Feature Revenue Growth of 237%April 21, 2022 | finance.yahoo.comSensus Healthcare to Host First Quarter 2022 Financial Results and Business Update Conference Call on May 5, 2022April 17, 2022 | finance.yahoo.comSensus Healthcare, Inc.'s (NASDAQ:SRTS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?March 25, 2022 | finance.yahoo.comSensus Healthcare, Inc. (SRTS) Moves 7.3% Higher: Will This Strength Last?March 24, 2022 | finance.yahoo.comMata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University VeterinarianSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SRTS CUSIPN/A CIK1494891 Webwww.sensushealthcare.com Phone(561) 922-5808Fax561-948-2071Employees37Year FoundedN/ACompany Calendar Last Earnings5/05/2022Today6/30/2022Next Earnings (Estimated)8/04/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$13.50 High Stock Price Forecast$14.00 Low Stock Price Forecast$13.00 Forecasted Upside/Downside+75.8%Consensus RatingBuy Rating Score (0-4)3 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$1.279990 Trailing P/E Ratio6.00 Forward P/E Ratio10.11 P/E GrowthN/ANet Income$4.12 million Net Margins62.07% Pretax Margin63.96% Return on Equity31.17% Return on Assets24.66% Debt Debt-to-Equity RatioN/A Current Ratio4.72 Quick Ratio4.50 Sales & Book Value Annual Sales$27.04 million Price / Sales4.74 Cash Flow$0.27 per share Price / Cash Flow28.16 Book Value$1.57 per share Price / Book4.89Miscellaneous Outstanding Shares16,678,000Free Float12,625,000Market Cap$128.09 million OptionableNot Optionable Beta0.51 Sensus Healthcare Frequently Asked Questions Should I buy or sell Sensus Healthcare stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sensus Healthcare stock. View analyst ratings for Sensus Healthcare or view top-rated stocks. What is Sensus Healthcare's stock price forecast for 2022? 2 brokers have issued 12 month price targets for Sensus Healthcare's shares. Their SRTS stock forecasts range from $13.00 to $14.00. On average, they anticipate Sensus Healthcare's share price to reach $13.50 in the next twelve months. This suggests a possible upside of 75.8% from the stock's current price. View analysts' price targets for Sensus Healthcare or view top-rated stocks among Wall Street analysts. How has Sensus Healthcare's stock performed in 2022? Sensus Healthcare's stock was trading at $7.22 at the beginning of the year. Since then, SRTS shares have increased by 6.4% and is now trading at $7.68. View the best growth stocks for 2022 here. When is Sensus Healthcare's next earnings date? Sensus Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Sensus Healthcare. How were Sensus Healthcare's earnings last quarter? Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its earnings results on Thursday, May, 5th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.14. The company had revenue of $10.34 million for the quarter, compared to the consensus estimate of $6.24 million. Sensus Healthcare had a trailing twelve-month return on equity of 31.17% and a net margin of 62.07%. During the same period in the previous year, the business earned ($0.07) EPS. View Sensus Healthcare's earnings history. Who are Sensus Healthcare's key executives? Sensus Healthcare's management team includes the following people: Mr. Joseph C. Sardano, Co-Founder, Chairman & CEO (Age 69, Pay $630.45k) (LinkedIn Profile)Mr. Michael J. Sardano, Pres & Gen. Counsel (Age 33, Pay $273.37k)Mr. Javier Rampolla, Chief Financial Officer (Age 49)Mr. Nicolas Soro, Chief Operating Officer (Age 37)Mr. Yonatan Vainer, Chief Technology Officer (Age 35)Mr. Benson Suen, VP of International SalesDr. Mark S. Nestor, Medical Director & Member of Medical Advisory BoardDr. Clay Jefferies Cockerell, Clinical Director & Member of Medical Advisory Board (Age 65) Who are some of Sensus Healthcare's key competitors? Some companies that are related to Sensus Healthcare include Orthofix Medical (OFIX), SI-BONE (SIBN), Sight Sciences (SGHT), IRadimed (IRMD), Inovio Pharmaceuticals (INO), MiMedx Group (MDXG), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), ClearPoint Neuro (CLPT), Liquidia (LQDA), Westaim (WEDXF), Social Capital Suvretta Holdings Corp. I (DNAA), Nyxoah (NYXH), SeaSpine (SPNE) and Apyx Medical (APYX). View all of SRTS's competitors. What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM). When did Sensus Healthcare IPO? (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. What is Sensus Healthcare's stock symbol? Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS." How do I buy shares of Sensus Healthcare? Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sensus Healthcare's stock price today? One share of SRTS stock can currently be purchased for approximately $7.68. How much money does Sensus Healthcare make? Sensus Healthcare (NASDAQ:SRTS) has a market capitalization of $128.09 million and generates $27.04 million in revenue each year. The company earns $4.12 million in net income (profit) each year or $1.279990 on an earnings per share basis. How many employees does Sensus Healthcare have? Sensus Healthcare employs 37 workers across the globe. How can I contact Sensus Healthcare? Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The official website for Sensus Healthcare is www.sensushealthcare.com. The company can be reached via phone at (561) 922-5808, via email at [email protected], or via fax at 561-948-2071. This page (NASDAQ:SRTS) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
